A novel mutation in PRPS1 causes X‐linked Charcot‐Marie‐Tooth disease‐5. Issue 5 (21st August 2019)

• Record Type: Journal Article
• Authors: Meng, Lingchao; Wang, Kang; Lv, He; Wang, Zhaoxia; Zhang, Wei; Yuan, Yun
• Is Part Of: Neuropathology. Volume 39:Issue 5(2019)
• Page Start: 342
• Page End: 347
• Publication Date: 2019-08-21
• Subjects: CMTX5 -- congenital deafness -- PRPS1 -- PRPS1 -- sural biopsy; Nervous system -- Diseases -- Periodicals; Nervous system -- Pathophysiology -- Periodicals; 616.8047
• DOI: 10.1111/neup.12589
• Languages: English
• ISSNs: 0919-6544

Abstract

Abstract : X‐linked Charcot‐Marie‐Tooth disease‐5 (CMTX5) is a rare hereditary disorder caused by mutations in the gene for phosphoribosyl pyrophosphate synthetase‐1 (PRPS1). We investigated a boy with a novel PRPS1 mutation (c.334G>C, p.V112L) via genetic, neuropathological and enzymatic tests. The proband was a 13‐year‐old boy with congenital non‐syndromic sensorineural deafness. At 3 year old, he developed progressive distal weakness of all limbs with muscle atrophy of both hands and shanks. Nerve conduction study revealed the loss of sensory nerve action potentials, and slowing down of motor nerve conduction velocities with a decrease of amplitudes of compound motor action potentials. Visual evoked potentials and brainstem auditory evoked potentials were not bilaterally evocable. Sural biopsy proved the loss of myelinated nerve fibers, with axonal degeneration, regenerating clusters and onion bulbs. Enzymatically, PRPS1 activity was close to zero in the proband and mildly reduced in his mother, compared with controls. To our knowledge, this is the first report of CMTX5 in a Chinese population. The genetic finding has expanded the genotypic spectrum of PRPS1 mutations.